Welcome to AI for Pharma
Artificial Intelligence is rapidly transforming the pharmaceutical industry — from drug discovery and manufacturing to quality systems, pharmacovigilance, and regulatory decision-making. At the same time, it raises fundamental questions about compliance, data integrity, validation, and responsibility.
AI for Pharma was created as a space to explore these changes in a practical, regulation-aware, and industry-focused way. The goal of this blog is to:
- Share recent news and developments related to AI in the pharmaceutical industry
- Discuss regulatory expectations (GxP, data integrity, validation, EU AI Act, FDA perspectives, etc.)
- Translate complex AI concepts into clear, usable insights for quality, manufacturing, and regulatory professionals
- Highlight realistic use cases, risks, and limitations — not hype
This initiative is particularly focused on compliance-critical environments, where innovation must coexist with:
- Patient safety
- Product quality
- Regulatory accountability
AI has enormous potential, but in pharma it must be understood, governed, and implemented responsibly.
I hope this blog will become a useful and interesting resource for:
- Quality and compliance professionals
- Manufacturing and validation experts
- Regulatory affairs specialists
- Anyone interested in the intersection of AI and pharmaceutical regulations
This is just the beginning. Future posts will cover examples, regulatory interpretations, lessons learned, and emerging trends.
Welcome — and thank you for reading!